# Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies

> **NCT01745913** · PHASE2 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 2 (actual)

## Conditions studied

- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Acute Lymphocytic Leukemia
- Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma

## Interventions

- **DEVICE:** CliniMACS® CD34 Reagent System
- **DRUG:** Fludarabine
- **DRUG:** Melphalan
- **DRUG:** Rabbit ATG
- **PROCEDURE:** Double Umbilical Cord Blood Transplantation
- **PROCEDURE:** Haplo-Identical Cord Transplantation

## Key facts

- **NCT ID:** NCT01745913
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10-26
- **Primary completion:** 2015-04-29
- **Final completion:** 2015-04-29
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2018-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01745913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01745913, "Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01745913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*